Kevin Quon
Insider ownership, small-cap, long-term horizon, dividend investing

Pacific Biosciences: Higher Expectations Return As Support Grows For This Gene Sequencer

Pacific Biosciences of California (PACB) surged intraday on Friday after its 2Q 2013 earnings release. By midday, the company's stock had jumped over 8%. Pacific Biosciences is a developing manufacturer of DNA sequencing systems used by large institutions for genetic sequencing. The company has developed and now manufactures an integrated platform for genetic analysis utilizing what it terms as single molecule, real-time technology [SMRT] for the detection of biological processes.

Recovering From The First Blow

Unfortunately, it has been a rough journey trading on the public markets for Pacific Biosciences. Following its IPO in late 2010 at $16/share, the company soon ran into problems in regards to its novel system appropriately named the PacBio RS. Plagued with system...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details